Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP

Journal of Controlled Release

Volumn 50, Issue 1-3, 1998, Pages 41-49

  Leone Bay, Andrea ^a   Paton, Duncan R ^a   Variano, Bruce ^a   Leipold, Harry ^a   Rivera, Theresa ^a   Miura Fraboni, Judy ^a   Baughman, Robert A ^a   Santiago, Noemi ^a  

^a Emisphere Technologies Inc   (United States)

Author keywords

Amido acids; Heparin; Oral anticoagulant; Oral drug delivery

Indexed keywords

AMINO ACID DERIVATIVE; HEPARIN; METHYLENE BLUE; MICROSPHERE;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; MALE; MONKEY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AMINO ACIDS; ANIMALS; ANTICOAGULANTS; CHROMATOGRAPHY, AFFINITY; DRUG DELIVERY SYSTEMS; FEMALE; HEPARIN; INTESTINAL ABSORPTION; MACACA FASCICULARIS; MALE; PARTIAL THROMBOPLASTIN TIME; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032472294     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00101-6     Document Type: Article

References (21)

1. Gallus A.S. Anticoagulants in the prevention of venous thromboembolism. Baillieres Clin. Haematol. 3:1990;651-684.
2. J.B. Hardman, L.E. Limbird, Anticoagulants, thrombolytic, and antiplatelet drugs, in: Goodman and Gilman's The Pharmacological Basis of Therapeutic, Macmillan, New York, 1996, pp. 1344-1346.
3. J.P. Griffin, P.F. D'Arcy, C.J. Speirs, Anticoagulants, in: A Manual of Adverse Drug Interactions, John Wright, London, 1988, pp. 137-158.
4. DalPozzo A., Acquasaliente M., Geron M.R. New heparin complexes active by intestinal absorption. I. Multiple ion pairs with basic organic compounds. Thromb. Res. 56:1989;119-124.
5. Caramazza I., D'Atri G., Bossi M.L., DePonti F., D'Angelo L., Crema A. Intraduodenal absorption of the new UF-heparin salt ITF 1057 in the conscious dog. Thromb. Res. 62:1991;785-789.
6. Morton A.K., Edwards H.E., Allen J.C., Phillips G.O. An evaluation of the oral administration of commercial and fractionated heparin samples in rats. Int. J. Pharm. 9:1982;321-335.
7. Sue T.K., Jaques L.B., Yuen E. Effects of acidity, cations, and alcoholic fractionation on absorption of heparin from the gastrointestinal tract. Can. J. Physiol. Pharmacol. 54:1976;613-618.
8. Engel R.H., Riggi S.J. Intestinal absorption of heparin facilitated by sulphated or sulfonated surfactants. Proc. Soc. Exp. Bio. Med. 130:1969;706-710.
9. Guarini S., Ferrari W. Olive oil-provoked, bile-dependant absorption of heparin from the gastrointestinal tract in rats. Pharm. Res. Commun. 17:1985;685-694.
10. Ueno M., Nakasake T., Horikoshi I., Sakuragawa N. Oral administration of liposomally- entrapped heparin to beagle dogs. Chem. Pharm. Bull. 30:1982;2245-2247.
11. Windsor E., Cronheim G.E. Gastrointestinal absorption of heparin and synthetic heparinoids. Nature. 190:1961;263-264.
12. Tidball C.S., Lipman R.I. Enhancement of jejunal absorption of heparinoid sodium ethylenediaminetetraacetate in the dog. Proc. Soc. Exp. Biol. Med. 111:1962;713-715.
13. S. Steiner, R. Rosen, Delivery system for pharmacological agents encapsulated with proteinoids, U.S. Patent 4, 925, 673, May 15, 1990.
14. Ma X., Santiago N., Chen Y., Chaudhary K., Milstein S.J., Baughman R.A. Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying. J. Drug Targ. 2:1994;9-21.
15. Leone-Bay A., Ho K-K., Agarwal R., Baughman R.A., Chaudhary K., DeMorin L., Genoble C., McInnes C., Lercara S., Milstein S., O'Toole D., Sarubbi D., Variano B., Paton D. 4-[4-(2-Hydroxybenzoyl)aminophenyl]butyric acid as a novel oral delivery agent for recombinant human growth hormone. J. Med. Chem. 39:1996;2571-2578.
16. J.B. Henry, Clinical Diagnosis and Management by Laboratory Methods, W.B. Saunders, Philadelphia, 1979.
17. G.M. Mlynek, Mechanistic studies on proteinoid-enhanced protein absorption across intestinal tissue: a novel oral peptide delivery system. University of Wisconsin, Ph.D. Thesis, 1995.
18. W.A. Ritschel, G.B. Ritschel, Rectal administration of insulin, in: B. Glas, C.J. DeBalaey (Eds.), Rectal Therapy, J.R. Prous, Spain, 1984.
19. Lim Y., Mitra A.K. A simple method of correlating pharmacodynamic equivalence with absolute bioavailability following noninvasive delivery of insulin. Pharm. Res. 11:1994;1505-1508.
20. Sierra Nevada Laboratories, Inc. Hematology Department, Reno, Nevada.
21. Wallin A., Jaques L.B. Melachromasia: An explanation of the color change produced in dyes by heparin and other substances. Thromb. Res. 2:1973;337-382.